Professional Title & Qualifications:
Chief Physician, Professor, M.D., Ph.D., Doctoral Supervisor
Specialization:
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Urology
Dr. Dingwei Ye - Urologic Oncology Specialist
Personal Biography
Professor Dingwei Ye is the Vice President of Fudan University Shanghai Cancer Center (FUSCC) and the Academic Leader of the Urology Department. He also serves as the Chief Expert of the Multidisciplinary Team (MDT) for Urologic Tumors, Director of the Shanghai Urological Cancer Institute, and Director of the Fudan University Prostate Cancer Institute.
Professor Ye has extensive experience in the surgical and comprehensive treatment of genitourinary tumors. He performs nearly 1,000 radical surgeries annually. He has previously trained at the University of Texas MD Anderson Cancer Center. As a leading figure in his field, he has pioneered multiple minimally invasive surgical techniques and comprehensive treatment guidelines for urologic cancers in China.
Book an online consultation with Dr. Dingwei Ye
Areas of Expertise
-
Diagnosis and treatment of benign and malignant tumors of the genitourinary system (Prostate cancer, Bladder cancer, Kidney cancer, Testicular cancer, Adrenal tumors, Penile cancer, and Retroperitoneal tumors).
-
Minimally invasive surgery (including Da Vinci Robotic Surgery).
-
Comprehensive multidisciplinary treatment including chemotherapy, radiotherapy, immunotherapy, interventional therapy, and hormonal therapy for urologic cancers.
-
Early diagnosis and individualized treatment of prostate cancer.
Clinical Highlights
-
Over 19,600 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Work Experience
-
Vice President, Fudan University Shanghai Cancer Center.
-
Director, Department of Urology, Fudan University Shanghai Cancer Center.
-
Director, Shanghai Urological Cancer Institute.
-
Director, Fudan University Prostate Cancer Institute.
-
Principal Investigator, leading over 50 international and domestic multi-center clinical trials and research projects.
Social Appointments (Professional Memberships)
-
Chairman, Genitourinary Cancer Committee of the China Anti-Cancer Association (CACA).
-
Chairman, Prostate Cancer Committee of the Chinese Society of Clinical Oncology (CSCO).
-
Vice Chairman, CSCO Urothelial Carcinoma Committee.
-
Vice Chairman, CSCO Renal Cancer Committee.
-
Vice Chairman, CSCO Immunotherapy Committee.
-
Chairman, Urological Cancer Cooperation Group (UCOG) of Chinese Cancer Hospitals.
-
Executive Member, Asian Pacific Prostate Society (APPS).
-
Member, Expert Committee for NCCN Asia Consensus Guidelines (Prostate, Kidney, and Bladder Cancer).
-
Vice President, Shanghai Medical Doctor Association - Urologist Branch.
Honors & Awards
-
First Prize, Shanghai Science and Technology Progress Award (Principal Achiever, 2 times).
-
First Prize, Science and Technology Achievement Award of the Ministry of Education (Principal Achiever).
-
First Prize, Shanghai Medical Science and Technology Award (Principal Achiever).
-
National Science and Technology Progress Award (First Prize, 3rd Achiever).
-
Wu Jieping Urology Award.
-
State Council Special Allowance Expert.
-
Shanghai Leading Talent & Shanghai Medical Leading Talent.
-
Outstanding Young and Middle-aged Expert with Outstanding Contributions (National Health Commission).
Research Achievements
-
Presided over more than 50 national and provincial-level scientific research funds.
-
Published over 540 academic papers as first or corresponding author (including 290+ SCI papers) in journals such as Nature Genetics, Journal of Clinical Oncology (JCO), European Urology (EU), and Clinical Cancer Research (CCR).
-
Editor-in-chief or translator of 9 medical monographs.
-
Holder of 19 invention and utility model patents.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.